Non-RBD peptides of SARS-CoV-2 spike protein exhibit immunodominance as they elicit both innate and adaptive immune responses

Non-RBD peptides of SARS-CoV-2 spike protein exhibit immunodominance as they elicit both innate and adaptive immune responses

Severe acute respiratory coronavirus-2 (SARS-CoV-2) emerged in 2019 as a new virus and caused worldwide outbreaks, quickly turning into a pandemic disease called coronavirus disease-19 (COVID-19). All the existing methodologies were used for developing vaccines for this virus. But sporadic infection...

Full description

Saved in:
Bibliographic Details
Main Authors: Deepika Rathore, Preeti Chauhan, Anvesh Bonagiri, Lekha Gandhi, Deepti Maisnam, Ramesh Kumar, Anupama T. Row, M.M. Kesavulu, Musturi Venkataramana
Format: Article
Language:English
Published: Elsevier 2024-11-01
Series:Heliyon
Subjects:
SARS-CoV-2
COVID-19
Vaccines
Spike protein
Receptor binding domain
Peptide vaccines
Online Access:http://www.sciencedirect.com/science/article/pii/S2405844024159725
Tags: Add Tag
No Tags, Be the first to tag this record!

Similar Items

Similar Items